Application Information

This drug has been submitted to the FDA under the reference 208524/001.

Names and composition

"BELVIQ XR" is the commercial name of a drug composed of LORCASERIN HYDROCHLORIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
208524/001 BELVIQ XR LORCASERIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 20MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022529/001 BELVIQ LORCASERIN HYDROCHLORIDE TABLET/ORAL 10MG
208524/001 BELVIQ XR LORCASERIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 20MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved